Price, P <br/><br/>
High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor.  [electronic resource] 

 -  The Journal of clinical investigation  Oct 1984 
 - 1496-508 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0021-9738 
<br/><br/><label>Standard No.: </label>10.1172/JCI111563  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3-Oxo-5-alpha-Steroid 4-Dehydrogenase--deficiency<br/>Adolescent<br/>Adult<br/>Dihydrotestosterone--blood<br/>Disorders of Sex Development--drug therapy<br/>Fibroblasts--metabolism<br/>Humans<br/>Luteinizing Hormone--blood<br/>Male<br/>Nitrogen--metabolism<br/>Oxidoreductases--deficiency<br/>Receptors, Androgen--deficiency<br/>Receptors, Steroid--deficiency<br/>Sex Characteristics<br/>Sperm Count<br/>Testosterone--blood